Cargando…

High-throughput proteomic analysis reveals systemic dysregulation in virally suppressed people living with HIV

BACKGROUND: People living with HIV (PLHIV) receiving antiretroviral therapy (ART) exhibit persistent immune dysregulation and microbial dysbiosis, leading to development of cardiovascular diseases (CVDs). We initially compared plasma proteomic profiles between 205 PLHIV and 120 healthy control parti...

Descripción completa

Detalles Bibliográficos
Autores principales: Vadaq, Nadira, Zhang, Yue, Vos, Wilhelm A.J.W., Groenendijk, Albert L., Blaauw, Martinus J.T., van Eekeren, Louise E., Jacobs-Cleophas, Maartje, van de Wijer, Lisa, dos Santos, Jéssica Cristina, Gasem, Muhammad Hussein, Joosten, Leo A.B., Netea, Mihai G., de Mast, Quirijn, Fu, Jingyuan, van der Ven, André J.A.M., Matzaraki, Vasiliki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393229/
https://www.ncbi.nlm.nih.gov/pubmed/37079385
http://dx.doi.org/10.1172/jci.insight.166166
_version_ 1785083121401593856
author Vadaq, Nadira
Zhang, Yue
Vos, Wilhelm A.J.W.
Groenendijk, Albert L.
Blaauw, Martinus J.T.
van Eekeren, Louise E.
Jacobs-Cleophas, Maartje
van de Wijer, Lisa
dos Santos, Jéssica Cristina
Gasem, Muhammad Hussein
Joosten, Leo A.B.
Netea, Mihai G.
de Mast, Quirijn
Fu, Jingyuan
van der Ven, André J.A.M.
Matzaraki, Vasiliki
author_facet Vadaq, Nadira
Zhang, Yue
Vos, Wilhelm A.J.W.
Groenendijk, Albert L.
Blaauw, Martinus J.T.
van Eekeren, Louise E.
Jacobs-Cleophas, Maartje
van de Wijer, Lisa
dos Santos, Jéssica Cristina
Gasem, Muhammad Hussein
Joosten, Leo A.B.
Netea, Mihai G.
de Mast, Quirijn
Fu, Jingyuan
van der Ven, André J.A.M.
Matzaraki, Vasiliki
author_sort Vadaq, Nadira
collection PubMed
description BACKGROUND: People living with HIV (PLHIV) receiving antiretroviral therapy (ART) exhibit persistent immune dysregulation and microbial dysbiosis, leading to development of cardiovascular diseases (CVDs). We initially compared plasma proteomic profiles between 205 PLHIV and 120 healthy control participants (HCs) and validated the results in an independent cohort of 639 PLHIV and 99 HCs. Differentially expressed proteins (DEPs) were then associated to microbiome data. Finally, we assessed which proteins were linked with CVD development in PLHIV. METHODS: Proximity extension assay technology was used to measure 1,472 plasma proteins. Markers of systemic inflammation (C-reactive protein, D-dimer, IL-6, soluble CD14, and soluble CD163) and microbial translocation (IFABP) were measured by ELISA, and gut bacterial species were identified using shotgun metagenomic sequencing. Baseline CVD data were available for all PLHIV, and 205 PLHIV were recorded for development of CVD during a 5-year follow-up. RESULTS: PLHIV receiving ART had systemic dysregulation of protein concentrations, compared with HCs. Most of the DEPs originated from the intestine and lymphoid tissues and were enriched in immune- and lipid metabolism–related pathways. DEPs originating from the intestine were associated with specific gut bacterial species. Finally, we identified upregulated proteins in PLHIV (GDF15, PLAUR, RELT, NEFL, COL6A3, and EDA2R), unlike most markers of systemic inflammation, associated with the presence and risk of developing CVD during 5-year follow-up. CONCLUSION: Our findings suggest a systemic dysregulation of protein concentrations in PLHIV; some proteins were associated with CVD development. Most DEPs originated from the gut and were related to specific gut bacterial species. TRIAL REGISTRATION: ClinicalTrials.gov NCT03994835. FUNDING: AIDS-fonds (P-29001), ViiV healthcare grant (A18-1052), Spinoza Prize (NWO SPI94-212), European Research Council (ERC) Advanced grant (grant 833247), and Indonesia Endowment Fund for Education.
format Online
Article
Text
id pubmed-10393229
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Society for Clinical Investigation
record_format MEDLINE/PubMed
spelling pubmed-103932292023-08-02 High-throughput proteomic analysis reveals systemic dysregulation in virally suppressed people living with HIV Vadaq, Nadira Zhang, Yue Vos, Wilhelm A.J.W. Groenendijk, Albert L. Blaauw, Martinus J.T. van Eekeren, Louise E. Jacobs-Cleophas, Maartje van de Wijer, Lisa dos Santos, Jéssica Cristina Gasem, Muhammad Hussein Joosten, Leo A.B. Netea, Mihai G. de Mast, Quirijn Fu, Jingyuan van der Ven, André J.A.M. Matzaraki, Vasiliki JCI Insight Clinical Medicine BACKGROUND: People living with HIV (PLHIV) receiving antiretroviral therapy (ART) exhibit persistent immune dysregulation and microbial dysbiosis, leading to development of cardiovascular diseases (CVDs). We initially compared plasma proteomic profiles between 205 PLHIV and 120 healthy control participants (HCs) and validated the results in an independent cohort of 639 PLHIV and 99 HCs. Differentially expressed proteins (DEPs) were then associated to microbiome data. Finally, we assessed which proteins were linked with CVD development in PLHIV. METHODS: Proximity extension assay technology was used to measure 1,472 plasma proteins. Markers of systemic inflammation (C-reactive protein, D-dimer, IL-6, soluble CD14, and soluble CD163) and microbial translocation (IFABP) were measured by ELISA, and gut bacterial species were identified using shotgun metagenomic sequencing. Baseline CVD data were available for all PLHIV, and 205 PLHIV were recorded for development of CVD during a 5-year follow-up. RESULTS: PLHIV receiving ART had systemic dysregulation of protein concentrations, compared with HCs. Most of the DEPs originated from the intestine and lymphoid tissues and were enriched in immune- and lipid metabolism–related pathways. DEPs originating from the intestine were associated with specific gut bacterial species. Finally, we identified upregulated proteins in PLHIV (GDF15, PLAUR, RELT, NEFL, COL6A3, and EDA2R), unlike most markers of systemic inflammation, associated with the presence and risk of developing CVD during 5-year follow-up. CONCLUSION: Our findings suggest a systemic dysregulation of protein concentrations in PLHIV; some proteins were associated with CVD development. Most DEPs originated from the gut and were related to specific gut bacterial species. TRIAL REGISTRATION: ClinicalTrials.gov NCT03994835. FUNDING: AIDS-fonds (P-29001), ViiV healthcare grant (A18-1052), Spinoza Prize (NWO SPI94-212), European Research Council (ERC) Advanced grant (grant 833247), and Indonesia Endowment Fund for Education. American Society for Clinical Investigation 2023-06-08 /pmc/articles/PMC10393229/ /pubmed/37079385 http://dx.doi.org/10.1172/jci.insight.166166 Text en © 2023 Vadaq et al. https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Clinical Medicine
Vadaq, Nadira
Zhang, Yue
Vos, Wilhelm A.J.W.
Groenendijk, Albert L.
Blaauw, Martinus J.T.
van Eekeren, Louise E.
Jacobs-Cleophas, Maartje
van de Wijer, Lisa
dos Santos, Jéssica Cristina
Gasem, Muhammad Hussein
Joosten, Leo A.B.
Netea, Mihai G.
de Mast, Quirijn
Fu, Jingyuan
van der Ven, André J.A.M.
Matzaraki, Vasiliki
High-throughput proteomic analysis reveals systemic dysregulation in virally suppressed people living with HIV
title High-throughput proteomic analysis reveals systemic dysregulation in virally suppressed people living with HIV
title_full High-throughput proteomic analysis reveals systemic dysregulation in virally suppressed people living with HIV
title_fullStr High-throughput proteomic analysis reveals systemic dysregulation in virally suppressed people living with HIV
title_full_unstemmed High-throughput proteomic analysis reveals systemic dysregulation in virally suppressed people living with HIV
title_short High-throughput proteomic analysis reveals systemic dysregulation in virally suppressed people living with HIV
title_sort high-throughput proteomic analysis reveals systemic dysregulation in virally suppressed people living with hiv
topic Clinical Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393229/
https://www.ncbi.nlm.nih.gov/pubmed/37079385
http://dx.doi.org/10.1172/jci.insight.166166
work_keys_str_mv AT vadaqnadira highthroughputproteomicanalysisrevealssystemicdysregulationinvirallysuppressedpeoplelivingwithhiv
AT zhangyue highthroughputproteomicanalysisrevealssystemicdysregulationinvirallysuppressedpeoplelivingwithhiv
AT voswilhelmajw highthroughputproteomicanalysisrevealssystemicdysregulationinvirallysuppressedpeoplelivingwithhiv
AT groenendijkalbertl highthroughputproteomicanalysisrevealssystemicdysregulationinvirallysuppressedpeoplelivingwithhiv
AT blaauwmartinusjt highthroughputproteomicanalysisrevealssystemicdysregulationinvirallysuppressedpeoplelivingwithhiv
AT vaneekerenlouisee highthroughputproteomicanalysisrevealssystemicdysregulationinvirallysuppressedpeoplelivingwithhiv
AT jacobscleophasmaartje highthroughputproteomicanalysisrevealssystemicdysregulationinvirallysuppressedpeoplelivingwithhiv
AT vandewijerlisa highthroughputproteomicanalysisrevealssystemicdysregulationinvirallysuppressedpeoplelivingwithhiv
AT dossantosjessicacristina highthroughputproteomicanalysisrevealssystemicdysregulationinvirallysuppressedpeoplelivingwithhiv
AT gasemmuhammadhussein highthroughputproteomicanalysisrevealssystemicdysregulationinvirallysuppressedpeoplelivingwithhiv
AT joostenleoab highthroughputproteomicanalysisrevealssystemicdysregulationinvirallysuppressedpeoplelivingwithhiv
AT neteamihaig highthroughputproteomicanalysisrevealssystemicdysregulationinvirallysuppressedpeoplelivingwithhiv
AT demastquirijn highthroughputproteomicanalysisrevealssystemicdysregulationinvirallysuppressedpeoplelivingwithhiv
AT fujingyuan highthroughputproteomicanalysisrevealssystemicdysregulationinvirallysuppressedpeoplelivingwithhiv
AT vandervenandrejam highthroughputproteomicanalysisrevealssystemicdysregulationinvirallysuppressedpeoplelivingwithhiv
AT matzarakivasiliki highthroughputproteomicanalysisrevealssystemicdysregulationinvirallysuppressedpeoplelivingwithhiv